AU3739400A - Flint polypeptide analogs - Google Patents

Flint polypeptide analogs

Info

Publication number
AU3739400A
AU3739400A AU37394/00A AU3739400A AU3739400A AU 3739400 A AU3739400 A AU 3739400A AU 37394/00 A AU37394/00 A AU 37394/00A AU 3739400 A AU3739400 A AU 3739400A AU 3739400 A AU3739400 A AU 3739400A
Authority
AU
Australia
Prior art keywords
polypeptide analogs
flint polypeptide
flint
analogs
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU37394/00A
Inventor
Gerald Wayne Becker
Fredric Jay Cohen
Patricia Ann Gonzalez-Dewhitt
John Edward Hale
Radmila Micanovic
Christy Michelle Newton
Timothy Wayne Noblitt
Radhakrishnan Rathmachalam
Sheng-Hung Rainbow Tschang
Derrick Ryan Witcher
Victor John Wroblewski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of AU3739400A publication Critical patent/AU3739400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU37394/00A 1999-03-30 2000-03-20 Flint polypeptide analogs Abandoned AU3739400A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US12683999P 1999-03-30 1999-03-30
US60126839 1999-03-30
US14007799P 1999-06-21 1999-06-21
US14015699P 1999-06-21 1999-06-21
US60140077 1999-06-21
US60140156 1999-06-21
US16056699P 1999-10-20 1999-10-20
US60160566 1999-10-20
US18339800P 2000-02-18 2000-02-18
US60183398 2000-02-18
PCT/US2000/006417 WO2000058465A2 (en) 1999-03-30 2000-03-20 Flint polypeptide analogs

Publications (1)

Publication Number Publication Date
AU3739400A true AU3739400A (en) 2000-10-16

Family

ID=27537769

Family Applications (1)

Application Number Title Priority Date Filing Date
AU37394/00A Abandoned AU3739400A (en) 1999-03-30 2000-03-20 Flint polypeptide analogs

Country Status (5)

Country Link
EP (1) EP1165780A2 (en)
JP (1) JP2002539828A (en)
AU (1) AU3739400A (en)
CA (1) CA2368760A1 (en)
WO (1) WO2000058465A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000070174A (en) 1997-01-14 2000-11-25 벤슨 로버트 에이치. Tumor necrosis factor receptors 6α and 6β
US7285267B2 (en) 1997-01-14 2007-10-23 Human Genome Sciences, Inc. Tumor necrosis factor receptors 6α & 6β
AU762959B2 (en) 1997-09-18 2003-07-10 Genentech Inc. DcR3 polypeptide, A TNFR homolog
WO2001018202A2 (en) * 1999-09-10 2001-03-15 Eli Lilly And Company Flint analog compounds and formulations thereof
WO2001028582A2 (en) * 1999-10-20 2001-04-26 Eli Lilly And Company Therapeutic applications of flint polypeptides
EP1244783A1 (en) * 1999-12-07 2002-10-02 Eli Lilly And Company Improving stability of flint through o-linked glycosylation
JP2005506282A (en) * 2001-02-01 2005-03-03 イーライ・リリー・アンド・カンパニー FLINT glycoform
WO2002060947A2 (en) * 2001-02-01 2002-08-08 Eli Lilly And Company Glycoforms a fas ligand inhibitory protein analog
CA2439193A1 (en) * 2001-02-23 2002-08-29 Hideki Matsui Casoase 3 inhibitors
KR100754667B1 (en) 2005-04-08 2007-09-03 한미약품 주식회사 Immunoglobulin Fc fragment modified by non-peptide polymer and pharmaceutical composition comprising the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000070174A (en) * 1997-01-14 2000-11-25 벤슨 로버트 에이치. Tumor necrosis factor receptors 6α and 6β
WO1999004001A1 (en) * 1997-07-21 1999-01-28 Zymogenetics, Inc. Tumor necrosis factor receptor ztnfr-5
AU762959B2 (en) * 1997-09-18 2003-07-10 Genentech Inc. DcR3 polypeptide, A TNFR homolog
EP1020521A1 (en) * 1998-12-09 2000-07-19 Eli Lilly And Company Fas Ligand inhibitor ( FLINT ) compositions and uses thereof
DE60036199T2 (en) * 1999-03-30 2008-05-21 Eli Lilly And Co., Indianapolis PROTEASERESISTENT FLINT ANALOG

Also Published As

Publication number Publication date
WO2000058465A2 (en) 2000-10-05
WO2000058465A3 (en) 2001-01-25
CA2368760A1 (en) 2000-10-05
JP2002539828A (en) 2002-11-26
EP1165780A2 (en) 2002-01-02

Similar Documents

Publication Publication Date Title
GB9923177D0 (en) Novel polypeptide
AU3739400A (en) Flint polypeptide analogs
AU4930399A (en) Novel Polypeptide
AU5706000A (en) Useful polypeptide
GB9923889D0 (en) Novel polypeptide
AU2691500A (en) Novel polypeptide
AU4778600A (en) Novel polypeptide
GB9924951D0 (en) Novel polypeptide
AU6550800A (en) Hepoxilin analogs
AU2232399A (en) Recombinant ctb-based vaccines
AU1184800A (en) Novel polypeptide
AU2109200A (en) Polypeptide
GB9923890D0 (en) Novel polypeptide
GB9923893D0 (en) Novel polypeptide
AU6712600A (en) Polypeptides
AU1228201A (en) Umlr polypeptides
AU6637700A (en) Tryptase-like polypeptide ztryp1
AU2002224056A1 (en) Novel polypeptide
GB9923888D0 (en) Novel polypeptide
GB9924960D0 (en) Novel polypeptide
GB9925115D0 (en) Novel polypeptide
AUPP704598A0 (en) Novel polypeptide
GB9924956D0 (en) Novel polypeptide
AU1316201A (en) Polypeptide composition
GB9918680D0 (en) Polypeptide

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase